Empowering emergency clinicians to rapidly recognize and act early on acute infections with unparalleled precision

*Defined as the risk of progression to needing mechanical ventilation, vasopressors, and/or renal replacement therapy (RRT) within seven days.

Each year up to 56 million patients visit emergency departments with suspected acute infections.¹

In up to half of these patients, physicians struggle to make proper diagnosis and prognosis and would welcome novel tools to assist them.²

Inflammatix host response diagnostics are powered by ‘reading’ the immune system. Our immune system has developed targeted responses to different types of infections and other diseases over millions of years of evolution.

Leveraging our expertise in bioinformatics, including machine learning and artificial intelligence, and molecular biology, we are harnessing the ability to interpret the immune response to develop tests aimed to help physicians make confident and timely clinical decisions.

Most infections are locally contained and do not penetrate into the bloodstream. This makes pathogen-targeting tests insensitive for infections. Immune cells fight the infection locally and then circulate into the blood, where we can measure their ‘signatures’ using mRNA profiles.